Biblio Discovery — Demo Discovery Service

15 results

Showing 1–15 · 0.29 seconds · RSS

Journal

American Journal of Hematology

Scopus

ISSN 0361-8609 · Wiley · 15 articles in the index

  1. Journal Article Full text

    Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management

    S. Vincent Rajkumar

    American Journal of Hematology · 2024 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Multiple myeloma accounts for approximately 10% of hematologic malignancies. DIAGNOSIS: The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven plasmacytoma plus evidence of one or more multiple myeloma defining events (MDE): CRAB (hypercalcemia, renal…

  2. Journal Article Full text

    Primary myelofibrosis: 2023 update on diagnosis, risk‐stratification, and management

    Ayalew Tefferi

    American Journal of Hematology · 2023 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal myeloproliferation that is often but not always accompanied by JAK2, CALR, or MPL mutations; additional features include bone marrow reticulin/collagen fibrosis, aberrant…

  3. Journal Article Full text

    Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management

    Shai O. Shimony; Maximilian F. Stahl; Richard Maury Stone

    American Journal of Hematology · 2023 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Acute myeloid leukemia (AML) is a frequently fatal bone marrow stem cell cancer characterized by unbridled proliferation of malignant marrow stem cells with associated infection, anemia, and bleeding. An improved understanding of pathophysiology, improvements in measurement…

  4. Journal Article Full text

    Multiple myeloma: 2022 update on diagnosis, risk stratification, and management

    S. Vincent Rajkumar

    American Journal of Hematology · 2022 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Multiple myeloma accounts for approximately 10% of hematologic malignancies. DIAGNOSIS: The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy-proven plasmacytoma plus evidence of one or more multiple myeloma defining events (MDE): CRAB (hypercalcemia, renal…

  5. Journal Article

    2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management

    Sandra P. Susanibar-Adaniya; Stefan Klaus Barta

    American Journal of Hematology · 2021 · English · OpenAlex Scopus

    Diffuse large B cell lymphoma (DLBCL), the most common type of Non-Hodgkin lymphoma (NHL), comprises a heterogeneous group of diseases with different biology, clinical presentations, and response to treatment. R-CHOP remains the mainstay of therapy and can achieve long-term disease control in…

  6. Journal Article Full text

    Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures

    Michael J. Hallek; Othman Al‐Sawaf

    American Journal of Hematology · 2021 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Chronic lymphocytic leukemia (CLL) is one of the most frequent types of leukemia. It typically occurs in elderly patients and has a highly variable clinical course. Leukemic transformation is initiated by specific genomic alterations that interfere with the regulation of…

  7. Journal Article Full text

    Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination

    Eun‐Ju Lee; Douglas B. Cines; Terry Gernsheimer et al.

    American Journal of Hematology · 2021 · English · OpenAlex Scopus

    Cases of apparent secondary immune thrombocytopenia (ITP) after SARS-CoV-2 vaccination with both the Pfizer and Moderna versions have been reported and reached public attention. Public alarm was heightened following the death of the first identified patient from an intracranial hemorrhage, which…

  8. Journal Article Full text

    POEMS syndrome: 2021 Update on diagnosis, risk‐stratification, and management

    Angela A. Dispenzieri

    American Journal of Hematology · 2021 · English · OpenAlex Scopus

    DISEASE OVERVIEW: POEMS syndrome is a paraneoplastic syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of…

  9. Journal Article Full text

    Recommendations for diagnosis and treatment of methemoglobinemia

    Achille Iolascon; Paola Ilaria Bianchi; Immacolata Andolfo et al.

    American Journal of Hematology · 2021 · English · OpenAlex Scopus

    Methemoglobinemia is a rare disorder associated with oxidization of divalent ferro-iron of hemoglobin (Hb) to ferri-iron of methemoglobin (MetHb). Methemoglobinemia can result from either inherited or acquired processes. Acquired forms are the most common, mainly due to the exposure to substances…

  10. Journal Article Full text

    Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management

    Ayalew Tefferi

    American Journal of Hematology · 2020 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal myeloproliferation that is often but not always accompanied by JAK2, CALR, or MPL mutations. Additional disease features include bone marrow reticulin/collagen fibrosis…

  11. Journal Article Full text

    Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring

    Elias Joseph Jabbour; Hagop M. Kantarjian

    American Journal of Hematology · 2020 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1-2 cases per 100 000 adults. It accounts for approximately 15% of newly diagnosed cases of leukemia in adults. DIAGNOSIS: CML is characterized by a balanced genetic translocation…

  12. Journal Article Full text

    Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management

    Ayalew Tefferi; Tiziano Barbui

    American Journal of Hematology · 2020 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPN) respectively characterized by clonal erythrocytosis and thrombocytosis; other disease features include leukocytosis, splenomegaly, thrombosis, bleeding, microcirculatory symptoms…

  13. Journal Article Full text

    Thrombosis in COVID ‐19

    Thomas C. Hanff; Amir M. Mohareb; Jay S. Giri et al.

    American Journal of Hematology · 2020 · English · OpenAlex Scopus

    Thrombotic complications are frequent in COVID-19 and contribute significantly to mortality and morbidity. We review several mechanisms of hypercoagulability in sepsis that may be upregulated in COVID-19. These include immune-mediated thrombotic mechanisms, complement activation, macrophage…

  14. Journal Article Full text

    Hematological findings and complications of COVID ‐19

    Evangelos Terpos; Ioannis Ntanasis‐Stathopoulos; Ismaı̈l Elalamy et al.

    American Journal of Hematology · 2020 · English · OpenAlex Scopus

    COVID-19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with prognostic potential. Neutrophil/lymphocyte ratio and peak platelet/lymphocyte ratio may also have prognostic value in…

  15. Journal Article Full text

    Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management

    S. Vincent Rajkumar

    American Journal of Hematology · 2020 · English · OpenAlex Scopus

    DISEASE OVERVIEW: Multiple myeloma accounts for approximately 10% of hematologic malignancies. DIAGNOSIS: The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven plasmacytoma plus evidence of one or more multiple myeloma defining events (MDE) namely CRAB (hypercalcemia, renal…